FOXD3 gene
Illumina Announces Layoffs as Incyte Forges AI Partnership for Drug Discovery
Illumina, layoffs, Incyte, Genesis Therapeutics, AI partnership, drug discovery, GEMS platform, small molecule therapeutics
Gilead Sciences and Genesis Therapeutics Collaborate on AI-Driven Small Molecule Drug Discovery
Gilead Sciences, Genesis Therapeutics, AI-driven drug discovery, small molecule therapies, strategic partnership, generative AI, drug development
Gilead and Genesis Therapeutics Partner on AI-Driven Small Molecule Therapies
AI drug discovery, Gilead Sciences, Genesis Therapeutics, small molecule therapies, generative AI, GEMS platform